The Patent Finder

Allozyne, Inc.

Also on record
Records under this name other than the patents Allozyne, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 8 of 8 · Back to Allozyne, Inc.

PatentTitleStatus Expires Confidence
US 10,253,345Cell Lines
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,131,920Nucleic acid molecules
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,981,908Amino acid derivatives
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,670,521Amino acid derivatives
Formerly held
Lapsed on the fee record
Ended Jun 6, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jun 6, 2025From the USPTO record
US 10,214,761Amino acid derivatives
Formerly held
Lapsed on the fee record
Ended Feb 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 26, 2023From the USPTO record
US 10,202,447Antibody derivatives
Lapsed on the fee record
Ended Feb 12, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 12, 2023From the USPTO record
US 7,632,492Modified Human Interferon-Beta Polypeptides
Lapsed on the fee record
Ended Dec 15, 2021 · High confidence
Lapsed on the fee recordEnded Dec 15, 2021High confidence
US 8,568,706Modified Human Interferon-Beta Polypeptides
Lapsed on the fee record
Ended Oct 29, 2021 · Medium confidence
Lapsed on the fee recordEnded Oct 29, 2021Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited